Association of the CHADS2 and CHA2DS2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients

Journal of Thrombosis and Thrombolysis

Volumn 40, Issue 2, 2015, Pages 240-247

  Hrynkiewicz Szymanska, Anna ^a   Dluzniewski, Miroslaw ^a   Platek, Anna E ^a   Szymanski, Filip M ^a   Syska Suminska, Joanna ^a   Klos Szadryn, Agnieszka ^a   Glinka, Marta ^a   Strojek, Malgorzata ^a   Kuciej, Alicja ^a   Tomaszewska Kiecana, Monika ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Atrial fibrillation; CHA2DS2 VASc; CHADS2; Left atrial enlargement; Stroke risk

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHA2DS2 VASC SCORE; CHADS2 SCORE; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT ATRIUM DIAMETER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICULAR ENDDIASTOLIC DIAMETER; HEART RIGHT VENTRICULAR DIAMETER; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TRANSTHORACIC ECHOCARDIOGRAPHY; CLINICAL TRIAL; COMPLICATION; ELECTROCARDIOGRAPHY; HEART ATRIUM; MIDDLE AGED; PATHOPHYSIOLOGY; THROMBOEMBOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOEMBOLISM;

EID: 84931567701     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1154-6     Document Type: Article

References (34)

1. Kirchhof P, Auricchio A, Bax J et al (2005) Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 28:2803–2817
2. Camm AJ, Kirchhof P, Lip GY, European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429
3. Camm AJ, Lip GY, De Caterina R, ESC Committee for Practice Guidelines (CPG) et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719–2747
4. Gage BF, Waterman AD, Shannon W et al (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870
5. Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 137:263–272
6. Szymanski FM, Filipiak KJ, Platek AE et al (2014) Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation. Sleep Breath. doi:10.1007/s11325-014-1042-5
7. The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 116:6–12
8. Lee JM, Shim J, Uhm JS et al (2014) Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillation. Am J Cardiol 113:963–969
9. Kiliszek M, Miązek N, Peller M et al (2014) Influence of left atrial size on outcome of pulmonary vein isolation in patients with atrial fibrillation. Kardiol Pol 72:1135–1140
10. Lemola K, Sneider M, Desjardins B et al (2004) Effects of left atrial ablation of atrial fibrillation on size of the left atrium and pulmonary veins. Heart Rhythm 1:576–581
11. Lang RM, Bierig M, Devereux RB, American Society of Echocardiography’s Nomenclature and Standards Committee, Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association, European Association of Echocardiography, European Society of Cardiology et al (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7:79–108
12. Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685–713
13. Kopeć G, Sobień B, Podolec M et al (2014) The prevalence of abnormal echocardiographic findings in a sample of urban adult population. Kardiol Pol 72:42–49
14. Lazoura O, Reddy T, Shriharan M et al (2012) Prevalence of left atrial anatomical abnormalities in patients with recurrent atrial fibrillation compared with patients in sinus rhythm using multi-slice CT. J Cardiovasc Comput Tomogr 6:268–273
15. Andersen JS, Egeblad H, Abildgaard U et al (1991) Atrial fibrillation and left atrial enlargement: cause or effect? J Intern Med 229:253–256
16. Parkash R, Green MS, Kerr CR, Canadian Registry of Atrial Fibrillation et al (2004) The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 148:649–654
17. Casaclang-Verzosa G, Gersh BJ, Tsang TS (2008) Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51:1–11
18. Dittrich HC, Pearce LA, Asinger RW et al (1999) Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J 137:494–499
19. Zhuang J, Wang Y, Tang K et al (2012) Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace 14:638–645
20. Kizer JR, Bella JN, Palmieri V et al (2006) Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 151:412–418
21. Scherr D, Dalal D, Chilukuri K et al (2009) Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 20:379–384
22. Olshansky B, Heller EN, Mitchell LB et al (2005) Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 45:2026–2033
23. Shin HY, Jeong IH, Kang CK et al (2013) Relation between left atrial enlargement and stroke subtypes in acute ischemic stroke patients. J Cerebrovasc Endovasc Neurosurg 15:131–136
24. Lip GY, Frison L, Halperin JL et al (2010) Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 41:2731–2738
25. 2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. Am J Med 127:45–52
26. 2-VASc-HS score. Am J Cardiol 113:950–956
27. Welles CC, Whooley MA, Na B et al (2011) The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study. Am Heart J 162:555–561
28. Willens HJ, Gómez-Marín O, Nelson K et al (2013) Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation. J Am Soc Echocardiogr 26:175–184
29. 2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 54:2032–2039
30. 2 score. Eur J Echocardiogr 10:383–388
31. Lip GY, Laroche C, Dan GA et al (2014) A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 16:308–319
32. Derezinski T, Wasikowska B, Strzebonski B et al (2013) Outpatient oral anticoagulation in Poland in 2012: a single centre experience. Kardiol Pol 71:1135–1139
33. Simpson E, Stevenson M, Scope A, Poku E, Minton J, Evans P (2013) Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation. Health Technol Assess 17:1–263
34. Faustino A, Providência R, Barra S et al (2014) Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation? Cardiovasc Ultrasound 12:28